Person · CIK 1253886

Patrick G Enright

Director at Jazz Pharmaceuticals, Zenas BioPharma, BioAge Labs, Vera Therapeutics and Veradermics; 10% owner at Rapid Micro Biosystems

Earlier: Lexeo Therapeutics, Aptinyx, Sierra Oncology, Inozyme Pharma, Talaris Therapeutics, Eargo, 89bio, Aimmune Therapeutics, Molecular Templates, Vaxcyte, Venus Concept, Axonics Modulation Technologies, Tricida, Collegium Pharmaceutical, Kala Pharmaceuticals, Corcept Therapeutics, Esperion Therapeutics, Sequenom and Valentis

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$384M

Noticed on Form 144$1.6M

Bought on Form 4$181.1M

Companies25

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Jazz Pharmaceuticals JAZZ	Ordinary Shares	Directly	21,278	Aug 31, 2026 · Filing · EDGAR
Jazz Pharmaceuticals JAZZ	Ordinary Shares	By Longitude Venture Partners, L.P.	215,677	Feb 10, 2016 · Filing · EDGAR
Jazz Pharmaceuticals JAZZ	Ordinary Shares	By Longitude Venture	215,677	Nov 17, 2017 · Filing · EDGAR
Jazz Pharmaceuticals JAZZ	Ordinary Shares	By Longitude Capital Associates, L.P. (	4,600	Jan 5, 2016 · Filing · EDGAR
Jazz Pharmaceuticals JAZZ	Ordinary Shares	By Longitude Capital Associates, L.P.	4,323	Feb 10, 2016 · Filing · EDGAR
Jazz Pharmaceuticals JAZZ	Ordinary Shares	By Longitude Capital	4,323	Nov 17, 2017 · Filing · EDGAR
Zenas BioPharma ZBIO	Common Stock	Directly	11,990	Oct 9, 2025 · Filing · EDGAR
Zenas BioPharma ZBIO	Common Stock	See Footnote	774,530	Oct 9, 2025 · Filing · EDGAR
Zenas BioPharma ZBIO	Stock Option (Right to Buy) exercise $18.71, expires Jun 15, 2036, into Common Stock	Directly	18,500	Jun 15, 2026 · Filing · EDGAR
BioAge Labs BIOA	Common Stock	Longitude Venture Partners IV, L.P.	1,710,589	Sep 27, 2024 · Filing · EDGAR
BioAge Labs BIOA	Stock Option (Right to Buy) exercise $15.48, expires Jun 9, 2036, into Common Stock	Directly	22,000	Jun 10, 2026 · Filing · EDGAR
Vera Therapeutics VERA	Class A Common Stock	Directly	5,882	Dec 11, 2025 · Filing · EDGAR
Vera Therapeutics VERA	Class A Common Stock	See footnote	3,596,593	Dec 11, 2025 · Filing · EDGAR
Vera Therapeutics VERA	Stock Option (right to buy) exercise $34.35, expires May 20, 2036, into Class A Common Stock	Directly	17,084	May 21, 2026 · Filing · EDGAR
Rapid Micro Biosystems RPID	Class A Common Stock	Held by Longitude Venture Partners II, L.P.	4,029,245	Feb 4, 2026 · Filing · EDGAR
Rapid Micro Biosystems RPID	Class A Common Stock	By Longitude Venture Partners II, L.P.	63,914	Jul 14, 2021 · Filing · EDGAR
Veradermics MANE	Common Stock	See Footnote	2,053,474	Feb 5, 2026 · Filing · EDGAR
Veradermics MANE	Stock Option (Right to Buy) exercise $17.00, expires Feb 3, 2036, into Common Stock	Directly	45,131	Feb 3, 2026 · Filing · EDGAR
Lexeo Therapeutics	Common Stock	By Longitude Venture Partners IV, L.P.	2,567,100	Nov 7, 2023 · Filing · EDGAR
Aptinyx	Common Stock	Directly	95,000	Jan 10, 2020 · Filing · EDGAR
Aptinyx	Common Stock	By: Longitude Venture Partners II, L.P.	3,356,746	Jan 10, 2020 · Filing · EDGAR
Aptinyx	Stock Option (Right to Buy) exercise $0.50, expires May 25, 2032, into Common Stock	Directly	40,000	May 26, 2022 · Filing · EDGAR
Sierra Oncology	Common Stock	See footnote	8,015	Apr 27, 2022 · Filing · EDGAR
Inozyme Pharma	Common Stock	By Longitude Venture Partners III, L.P.	4,174,379	Apr 19, 2022 · Filing · EDGAR
Talaris Therapeutics	Common Stock	By Longitude Venture Partners III, L.P.	3,220,775	May 11, 2021 · Filing · EDGAR
Eargo	Common Stock	Directly	2,918,691	Apr 14, 2021 · Filing · EDGAR
Eargo	Common Stock	See Footnote	5,012	Apr 14, 2021 · Filing · EDGAR
89bio	Common Stock	See footnote	891	Nov 16, 2020 · Filing · EDGAR
Aimmune Therapeutics	Common Stock, $0.0001 par value	By: Longitude Venture Partners II, L.P.	6,013,134	May 25, 2017 · Filing · EDGAR
Aimmune Therapeutics	Common Stock, $0.0001 par value	By Longitude Venture Partners II, L.P.	6,013,134	Nov 29, 2016 · Filing · EDGAR
Aimmune Therapeutics	Common Stock	By LVP2	6,013,134	Feb 22, 2018 · Filing · EDGAR
Molecular Templates	Common Stock, $0.001 par value	Directly	496	Apr 20, 2006 · Filing · EDGAR
Molecular Templates	Common Stock	By Longitude Venture Partners III, L.P.	3,199,035	Aug 28, 2020 · Filing · EDGAR
Molecular Templates	Common Stock	See Footnote	3,495	Aug 28, 2020 · Filing · EDGAR
Vaxcyte	Series A Preferred Stock into Common Stock	By Longitude Venture Partners II, L.P.	1,912,237	Jun 11, 2020 · Filing · EDGAR
Vaxcyte	Series B Preferred Stock into Common Stock	By Longitude Venture Partners II, L.P.	1,064,940	Jun 11, 2020 · Filing · EDGAR
Vaxcyte	Series C Preferred Stock into Common Stock	By Longitude Venture Partners II, L.P.	397,960	Jun 11, 2020 · Filing · EDGAR
Vaxcyte	Series D Preferred Stock into Common Stock	By Longitude Venture Partners II, L.P.	231,213	Jun 11, 2020 · Filing · EDGAR
Venus Concept	Common Stock	By Longitude Venture Partners II, L.P	3,666,119	Nov 7, 2019 · Filing · EDGAR
Axonics Modulation Technologies	Common Stock	By Longitude Venture Partners III, L.P.	2,933,333	Nov 2, 2018 · Filing · EDGAR
Tricida	Common Stock	Longitude Venture Partners II, L.P	3,019,734	Jul 2, 2018 · Filing · EDGAR
Tricida	Common Stock	Longitude Venture Partners II, L.P.	2,888,155	Jul 2, 2018 · Filing · EDGAR
Collegium Pharmaceutical	Common Stock	By Longitude Venture Partners, L.P.	3,256,572	May 12, 2015 · Filing · EDGAR
Collegium Pharmaceutical	Common Stock	By LVP	2,276,222	Dec 8, 2017 · Filing · EDGAR
Collegium Pharmaceutical	Common Stock	By Longitude Capital Associates, L.P.	65,270	May 12, 2015 · Filing · EDGAR
Collegium Pharmaceutical	Common Stock	By LCA	45,620	Dec 8, 2017 · Filing · EDGAR
Kala Pharmaceuticals	Common Stock	By Longitude Venture Partners II, L.P.	2,270,946	Jul 25, 2017 · Filing · EDGAR
Corcept Therapeutics	Common Stock	Directly	272,281	Mar 16, 2017 · Filing · EDGAR
Corcept Therapeutics	Common Stock	By Partnerships	13,433,573	Mar 29, 2012 · Filing · EDGAR
Corcept Therapeutics	Common Stock	By Partnerships.	12,576,929	Jan 21, 2011 · Filing · EDGAR
Corcept Therapeutics	Common Stock	By Longitude Venture Partners, L.P.	12,510,581	May 2, 2014 · Filing · EDGAR
Corcept Therapeutics	Common Stock	By LVP	5,721,372	Mar 16, 2017 · Filing · EDGAR
Corcept Therapeutics	Common Stock	By Longitude Capital Associates, L.P.	172,992	May 2, 2014 · Filing · EDGAR
Corcept Therapeutics	Common Stock	By LCA	114,675	Mar 16, 2017 · Filing · EDGAR
Esperion Therapeutics	Common Stock	By Longitude Venture Partners, L.P.	1,896,385	Jul 1, 2013 · Filing · EDGAR
Esperion Therapeutics	Common Stock	By LVP	916,035	Mar 19, 2015 · Filing · EDGAR
Esperion Therapeutics	Common Stock	By Longitude Capital Associates, L.P.	38,011	Jul 1, 2013 · Filing · EDGAR
Esperion Therapeutics	Common Stock	By LCA	18,361	Mar 19, 2015 · Filing · EDGAR
Sequenom	Common Stock, $0.001 par value	Directly	771	Dec 7, 2006 · Filing · EDGAR
Sequenom	Common Stock, $0.001 par value	Investment Advisor	3,333,333	Dec 7, 2006 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q3 2026	—	$858K	—
Q1 2026	$664K	—	$18.3M
Q4 2025	—	—	$2.5M
Q3 2025	—	$418K	—
Q2 2025	—	—	$5.3M
Q3 2024	—	—	$14.7M
Q4 2023	—	—	$5M
Q3 2023	$171K	$346K	—
Q1 2023	—	—	$12M
Q4 2022	$1M	Not machine-readable	—
Q3 2022	$166K	Not machine-readable	—
Q2 2022	—	—	$5M
Q1 2022	—	—	$9.7M
Q3 2021	—	—	$3M
Q2 2021	—	—	$14M
Q4 2020	$1.5M	Not machine-readable	$4.2M
Q3 2020	$38K	Not machine-readable	$13M
Q1 2020	—	—	$2.2M
Q4 2019	—	—	$16.7M
Q3 2019	$98K	Not machine-readable	—
Q4 2018	—	—	$8M
Q3 2018	$1.9M	Not machine-readable	$4.5M
Q2 2018	—	—	$2.4M
Q1 2018	—	—	$499K
Q4 2017	$18.6M	Not machine-readable	—
Q3 2017	$146K	Not machine-readable	$3.2M
Q1 2017	$38.1M	Not machine-readable	—
Q4 2016	$7.3M	Not machine-readable	—
Q3 2016	$86K	Not machine-readable	—
Q1 2016	$2.6M	Not machine-readable	$2.2M
Q4 2015	$4.2M	Not machine-readable	—
Q3 2015	$5.5M	Not machine-readable	$10M
Q2 2015	$5.2M	Not machine-readable	$2.4M
Q1 2015	$67.1M	Not machine-readable	—
Q4 2014	$21.8M	Not machine-readable	—
Q3 2014	$1.8M	Not machine-readable	—
Q2 2014	$2.1M	Not machine-readable	—
Q1 2014	$86.3M	Not machine-readable	—
Q3 2013	$88K	Not machine-readable	$3M
Q1 2013	$54.3M	Not machine-readable	—
Q4 2012	$3.9M	Not machine-readable	—
Q1 2012	$57M	Not machine-readable	—
Q1 2011	—	—	$2.9M
Q2 2010	—	—	$7M
Q4 2009	—	—	$3.4M
Q3 2009	—	—	$1.1M
Q1 2009	—	—	$3.2M
Q1 2007	$1.7M	Not machine-readable	—
Q4 2005	$596K	Not machine-readable	—
Q1 2005	—	—	$1.7M

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Jazz Pharmaceuticals JAZZ · Etrade Financial · No 10b5-1 plan stated · 3 notices
Aug 31, 2026	3,507 · ~$858K	Aug 31, 2026	Not sold yet	Filing · EDGAR
Aug 8, 2025	3,731 · ~$418K	Aug 8, 2025	Not sold within 90 days	Filing · EDGAR
Aug 14, 2023	2,561 · ~$346K	Aug 14, 2023	Partly sold Sold 1,241 at $138.16 on Aug 14 · $171K likely match Form 4	Filing · EDGAR
Sales without a matching Form 144 · 308 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Rapid Micro Biosystems (RPID): Sold 49,000 at $3.88 on Feb 4, 2026 · $190K	Filing · EDGAR
—	—	—	Sold without notice Rapid Micro Biosystems (RPID): Sold 27,500 at $4.24 on Feb 3, 2026 · $117K	Filing · EDGAR
—	—	—	Sold without notice Rapid Micro Biosystems (RPID): Sold 27,500 at $4.25 on Feb 2, 2026 · $117K	Filing · EDGAR
—	—	—	Sold without notice Rapid Micro Biosystems (RPID): Sold 46,000 at $4.54 on Jan 30, 2026 · $209K	Filing · EDGAR
—	—	—	Sold without notice Rapid Micro Biosystems (RPID): Sold 7,739 at $4.06 on Jan 23, 2026 · $31K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,000 at $152.88 on Nov 22, 2022 · $306K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,069 at $149.90 on Nov 22, 2022 · $310K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,905 at $149.18 on Nov 22, 2022 · $433K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,089 at $152.33 on Aug 8, 2022 · $166K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,623 at $147.61 on Nov 12, 2020 · $240K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5,083 at $147.00 on Nov 12, 2020 · $747K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,223 at $145.81 on Nov 12, 2020 · $470K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 1,049 at $10.75 on Aug 28, 2020 · $11K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 2,447 at $10.75 on Aug 28, 2020 · $26K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 726 at $135.65 on Aug 9, 2019 · $98K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,000 at $169.69 on Sep 6, 2018 · $170K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 7,086 at $168.86 on Sep 6, 2018 · $1.2M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,044 at $167.96 on Sep 6, 2018 · $343K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,365 at $175.13 on Aug 10, 2018 · $239K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,842 at $140.50 on Dec 11, 2017 · $399K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5,358 at $139.56 on Dec 11, 2017 · $748K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 800 at $138.15 on Dec 11, 2017 · $111K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Collegium Pharmaceutical: Sold 19,650 at $17.34 on Dec 8, 2017 · $341K	Filing · EDGAR
—	—	—	Notice not machine-readable Collegium Pharmaceutical: Sold 980,350 at $17.34 on Dec 8, 2017 · $17M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 352 at $133.19 on Nov 17, 2017 · $47K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 351 at $148.40 on Aug 25, 2017 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3 at $144.13 on Aug 11, 2017 · $432	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 659 at $142.36 on Aug 11, 2017 · $94K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 5,305 at $9.94 on Mar 16, 2017 · $53K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 264,650 at $9.94 on Mar 16, 2017 · $2.6M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 5,483 at $10.24 on Mar 15, 2017 · $56K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 273,537 at $10.24 on Mar 15, 2017 · $2.8M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 5,895 at $10.01 on Mar 14, 2017 · $59K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 294,105 at $10.01 on Mar 14, 2017 · $2.9M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 412 at $11.13 on Mar 13, 2017 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 20,568 at $11.13 on Mar 13, 2017 · $229K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 14,737 at $9.75 on Mar 8, 2017 · $144K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 735,263 at $9.75 on Mar 8, 2017 · $7.2M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 19,650 at $9.05 on Feb 27, 2017 · $178K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 980,350 at $9.05 on Feb 27, 2017 · $8.9M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 29,475 at $8.65 on Feb 23, 2017 · $255K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 1,470,525 at $8.65 on Feb 23, 2017 · $12.7M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 677 at $101.80 on Dec 2, 2016 · $69K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 290 at $9.39 on Nov 25, 2016 · $3K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 14,451 at $9.39 on Nov 25, 2016 · $136K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 248 at $9.30 on Nov 23, 2016 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 12,352 at $9.30 on Nov 23, 2016 · $115K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 189 at $9.33 on Nov 22, 2016 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 9,411 at $9.33 on Nov 22, 2016 · $88K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 2,327 at $9.39 on Nov 21, 2016 · $22K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 116,058 at $9.39 on Nov 21, 2016 · $1.1M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 1,976 at $9.47 on Nov 18, 2016 · $19K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 98,586 at $9.47 on Nov 18, 2016 · $934K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 6,389 at $9.64 on Nov 17, 2016 · $62K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 318,764 at $9.64 on Nov 17, 2016 · $3.1M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 342 at $9.51 on Nov 16, 2016 · $3K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 17,052 at $9.51 on Nov 16, 2016 · $162K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 3,094 at $9.55 on Nov 15, 2016 · $30K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 154,359 at $9.55 on Nov 15, 2016 · $1.5M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 633 at $136.45 on Aug 15, 2016 · $86K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 7 at $120.31 on Feb 10, 2016 · $842	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 34 at $119.55 on Feb 10, 2016 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 63 at $118.39 on Feb 10, 2016 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 52 at $117.46 on Feb 10, 2016 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 34 at $116.19 on Feb 10, 2016 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 6 at $114.43 on Feb 10, 2016 · $687	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 393 at $120.32 on Feb 10, 2016 · $47K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,666 at $119.55 on Feb 10, 2016 · $199K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,159 at $118.40 on Feb 10, 2016 · $374K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,594 at $117.46 on Feb 10, 2016 · $305K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,698 at $116.20 on Feb 10, 2016 · $197K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 294 at $114.43 on Feb 10, 2016 · $34K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 24 at $139.24 on Jan 5, 2016 · $3K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 57 at $138.37 on Jan 5, 2016 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 116 at $137.71 on Jan 5, 2016 · $16K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,214 at $139.24 on Jan 5, 2016 · $169K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,843 at $138.36 on Jan 5, 2016 · $393K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5,746 at $137.71 on Jan 5, 2016 · $791K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 424 at $148.49 on Dec 2, 2015 · $63K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 34 at $147.57 on Dec 1, 2015 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 68 at $146.95 on Dec 1, 2015 · $10K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 94 at $145.96 on Dec 1, 2015 · $14K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,737 at $147.58 on Dec 1, 2015 · $256K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,395 at $146.95 on Dec 1, 2015 · $499K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4,672 at $145.96 on Dec 1, 2015 · $682K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 18 at $137.96 on Nov 10, 2015 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 36 at $137.16 on Nov 10, 2015 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 32 at $135.85 on Nov 10, 2015 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 62 at $134.76 on Nov 10, 2015 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 34 at $133.95 on Nov 10, 2015 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 8 at $132.70 on Nov 10, 2015 · $1K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 6 at $128.96 on Nov 10, 2015 · $774	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 932 at $137.98 on Nov 10, 2015 · $129K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,809 at $137.15 on Nov 10, 2015 · $248K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,573 at $135.85 on Nov 10, 2015 · $214K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,138 at $134.76 on Nov 10, 2015 · $423K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,666 at $133.95 on Nov 10, 2015 · $223K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 392 at $132.70 on Nov 10, 2015 · $52K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 294 at $128.96 on Nov 10, 2015 · $38K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1 at $137.81 on Oct 5, 2015 · $138	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 34 at $136.60 on Oct 5, 2015 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 10 at $135.73 on Oct 5, 2015 · $1K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 25 at $134.32 on Oct 5, 2015 · $3K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 83 at $132.94 on Oct 5, 2015 · $11K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 43 at $132.26 on Oct 5, 2015 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 99 at $137.81 on Oct 5, 2015 · $14K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,695 at $136.60 on Oct 5, 2015 · $232K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 490 at $135.73 on Oct 5, 2015 · $67K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,225 at $134.32 on Oct 5, 2015 · $165K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4,193 at $132.94 on Oct 5, 2015 · $557K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,102 at $132.26 on Oct 5, 2015 · $278K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 37 at $168.33 on Sep 1, 2015 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 21 at $167.32 on Sep 1, 2015 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 24 at $166.36 on Sep 1, 2015 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 57 at $165.26 on Sep 1, 2015 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 57 at $164.50 on Sep 1, 2015 · $9K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,857 at $168.34 on Sep 1, 2015 · $313K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,081 at $167.33 on Sep 1, 2015 · $181K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,169 at $166.36 on Sep 1, 2015 · $194K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,846 at $165.27 on Sep 1, 2015 · $470K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,851 at $164.51 on Sep 1, 2015 · $469K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 425 at $167.87 on Aug 27, 2015 · $71K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 21 at $183.75 on Aug 10, 2015 · $4K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 23 at $182.69 on Aug 10, 2015 · $4K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 148 at $181.71 on Aug 10, 2015 · $27K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4 at $180.05 on Aug 10, 2015 · $720 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,069 at $183.77 on Aug 10, 2015 · $196K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,177 at $182.68 on Aug 10, 2015 · $215K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 7,362 at $181.71 on Aug 10, 2015 · $1.3M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 196 at $180.05 on Aug 10, 2015 · $35K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4 at $183.36 on Aug 10, 2015 · $733	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 797 at $179.98 on Aug 10, 2015 · $143K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 10 at $178.59 on Jul 6, 2015 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 60 at $177.74 on Jul 6, 2015 · $11K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 105 at $176.86 on Jul 6, 2015 · $19K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 22 at $175.81 on Jul 6, 2015 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 543 at $178.59 on Jul 6, 2015 · $97K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,986 at $177.74 on Jul 6, 2015 · $531K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5,196 at $176.86 on Jul 6, 2015 · $919K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,078 at $175.81 on Jul 6, 2015 · $190K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 47 at $179.43 on Jun 1, 2015 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 109 at $178.76 on Jun 1, 2015 · $19K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 40 at $177.82 on Jun 1, 2015 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,397 at $179.43 on Jun 1, 2015 · $430K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5,447 at $178.76 on Jun 1, 2015 · $974K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,960 at $177.82 on Jun 1, 2015 · $349K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 60 at $176.63 on May 11, 2015 · $11K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 137 at $175.98 on May 11, 2015 · $24K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,022 at $176.64 on May 11, 2015 · $534K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 6,781 at $175.98 on May 11, 2015 · $1.2M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 28 at $169.96 on Apr 6, 2015 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 125 at $169.23 on Apr 6, 2015 · $21K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 43 at $168.31 on Apr 6, 2015 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,402 at $169.97 on Apr 6, 2015 · $238K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 6,275 at $169.24 on Apr 6, 2015 · $1.1M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,127 at $168.32 on Apr 6, 2015 · $358K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 554,348 at $5.65 on Mar 24, 2015 · $3.1M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 4,617 at $5.85 on Mar 20, 2015 · $27K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 230,333 at $5.85 on Mar 20, 2015 · $1.3M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 300,447 at $5.85 on Mar 20, 2015 · $1.8M	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 123 at $116.05 on Mar 19, 2015 · $14K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 44 at $114.15 on Mar 19, 2015 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 3,907 at $113.92 on Mar 19, 2015 · $445K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 67 at $111.06 on Mar 19, 2015 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 5,684 at $110.01 on Mar 19, 2015 · $625K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 6,077 at $116.05 on Mar 19, 2015 · $705K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 2,156 at $114.15 on Mar 19, 2015 · $246K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 194,988 at $113.92 on Mar 19, 2015 · $22.2M	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 3,353 at $111.06 on Mar 19, 2015 · $372K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 283,601 at $110.01 on Mar 19, 2015 · $31.2M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3 at $177.51 on Mar 2, 2015 · $533	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 87 at $176.79 on Mar 2, 2015 · $15K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 57 at $176.03 on Mar 2, 2015 · $10K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 38 at $175.06 on Mar 2, 2015 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 12 at $172.60 on Mar 2, 2015 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 197 at $177.51 on Mar 2, 2015 · $35K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4,302 at $176.79 on Mar 2, 2015 · $761K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,854 at $176.02 on Mar 2, 2015 · $502K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,862 at $175.06 on Mar 2, 2015 · $326K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 588 at $172.60 on Mar 2, 2015 · $101K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3 at $168.13 on Feb 10, 2015 · $504	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 68 at $167.51 on Feb 10, 2015 · $11K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 125 at $166.45 on Feb 10, 2015 · $21K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 197 at $168.14 on Feb 10, 2015 · $33K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,382 at $167.51 on Feb 10, 2015 · $567K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 6,225 at $166.46 on Feb 10, 2015 · $1M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 9 at $161.54 on Jan 5, 2015 · $1K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 88 at $160.75 on Jan 5, 2015 · $14K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 100 at $159.68 on Jan 5, 2015 · $16K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 495 at $161.57 on Jan 5, 2015 · $80K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4,348 at $160.75 on Jan 5, 2015 · $699K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4,960 at $159.68 on Jan 5, 2015 · $792K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 300 at $172.53 on Dec 12, 2014 · $52K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 650 at $171.67 on Dec 12, 2014 · $112K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,393 at $170.32 on Dec 12, 2014 · $237K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5 at $177.10 on Dec 1, 2014 · $886	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 10 at $174.97 on Dec 1, 2014 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 48 at $173.73 on Dec 1, 2014 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 60 at $173.03 on Dec 1, 2014 · $10K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 25 at $171.65 on Dec 1, 2014 · $4K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 48 at $170.96 on Dec 1, 2014 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 295 at $177.10 on Dec 1, 2014 · $52K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 490 at $174.97 on Dec 1, 2014 · $86K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,403 at $173.73 on Dec 1, 2014 · $417K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,007 at $173.02 on Dec 1, 2014 · $520K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,208 at $171.65 on Dec 1, 2014 · $207K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,401 at $170.97 on Dec 1, 2014 · $410K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 8 at $32.13 on Nov 18, 2014 · $257	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 92 at $31.57 on Nov 18, 2014 · $3K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 412 at $32.14 on Nov 18, 2014 · $13K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 4,592 at $31.56 on Nov 18, 2014 · $145K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 2,722 at $33.79 on Nov 17, 2014 · $92K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 2,728 at $32.93 on Nov 17, 2014 · $90K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 4,021 at $32.01 on Nov 17, 2014 · $129K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 135,816 at $33.79 on Nov 17, 2014 · $4.6M	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 136,148 at $32.93 on Nov 17, 2014 · $4.5M	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 200,591 at $32.01 on Nov 17, 2014 · $6.4M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 46 at $171.71 on Nov 10, 2014 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 151 at $170.90 on Nov 10, 2014 · $26K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,258 at $171.71 on Nov 10, 2014 · $388K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 7,545 at $170.90 on Nov 10, 2014 · $1.3M	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 19 at $30.00 on Oct 9, 2014 · $570	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 924 at $30.00 on Oct 9, 2014 · $28K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 235 at $30.04 on Oct 7, 2014 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Esperion Therapeutics: Sold 11,692 at $30.04 on Oct 7, 2014 · $351K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 43 at $161.57 on Oct 6, 2014 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 104 at $160.65 on Oct 6, 2014 · $17K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 49 at $159.47 on Oct 6, 2014 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,157 at $161.57 on Oct 6, 2014 · $349K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5,197 at $160.65 on Oct 6, 2014 · $835K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,450 at $159.48 on Oct 6, 2014 · $391K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 38 at $163.88 on Sep 2, 2014 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 159 at $162.71 on Sep 2, 2014 · $26K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,909 at $163.89 on Sep 2, 2014 · $313K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 7,894 at $162.71 on Sep 2, 2014 · $1.3M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,087 at $133.15 on Aug 12, 2014 · $145K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 1,699 at $4.07 on May 2, 2014 · $7K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 84,744 at $4.07 on May 2, 2014 · $345K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 3,214 at $4.12 on May 1, 2014 · $13K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 160,343 at $4.12 on May 1, 2014 · $661K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 4,912 at $4.28 on Apr 1, 2014 · $21K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 245,088 at $4.28 on Apr 1, 2014 · $1M	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 205 at $4.00 on Mar 7, 2014 · $820	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 10,225 at $4.00 on Mar 7, 2014 · $41K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 3,303 at $4.00 on Mar 6, 2014 · $13K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 164,800 at $4.00 on Mar 6, 2014 · $659K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 1,404 at $4.01 on Mar 5, 2014 · $6K	Filing · EDGAR
—	—	—	Notice not machine-readable Corcept Therapeutics: Sold 70,063 at $4.01 on Mar 5, 2014 · $281K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,895 at $153.80 on Mar 3, 2014 · $599K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,166 at $150.45 on Mar 3, 2014 · $175K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,700 at $149.42 on Mar 3, 2014 · $553K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 2,700 at $148.55 on Mar 3, 2014 · $401K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 300 at $147.87 on Mar 3, 2014 · $44K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 8,731 at $150.50 on Feb 28, 2014 · $1.3M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 435,588 at $150.50 on Feb 28, 2014 · $65.6M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 559 at $159.03 on Feb 28, 2014 · $89K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 28,070 at $159.03 on Feb 28, 2014 · $4.5M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 423 at $159.91 on Feb 28, 2014 · $68K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 20,977 at $159.91 on Feb 28, 2014 · $3.4M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 180 at $160.77 on Feb 28, 2014 · $29K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 8,866 at $160.76 on Feb 28, 2014 · $1.4M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 787 at $161.93 on Feb 28, 2014 · $127K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 39,241 at $161.93 on Feb 28, 2014 · $6.4M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 71 at $162.94 on Feb 28, 2014 · $12K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,645 at $162.94 on Feb 28, 2014 · $594K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1 at $164.50 on Feb 28, 2014 · $165	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 28 at $164.50 on Feb 28, 2014 · $5K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 14 at $165.94 on Feb 28, 2014 · $2K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 686 at $165.94 on Feb 28, 2014 · $114K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,070 at $81.86 on Aug 13, 2013 · $88K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 15,720 at $58.28 on Mar 5, 2013 · $916K	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 784,280 at $58.28 on Mar 5, 2013 · $45.7M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 921 at $58.13 on Feb 19, 2013 · $54K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 46,451 at $58.13 on Feb 19, 2013 · $2.7M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 4 at $59.04 on Feb 15, 2013 · $236 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 375 at $58.41 on Feb 15, 2013 · $22K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 196 at $59.04 on Feb 15, 2013 · $12K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 18,703 at $58.41 on Feb 15, 2013 · $1.1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 456 at $56.72 on Jan 15, 2013 · $26K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 22,772 at $56.72 on Jan 15, 2013 · $1.3M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 31 at $56.54 on Jan 11, 2013 · $2K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,569 at $56.54 on Jan 11, 2013 · $89K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 706 at $56.52 on Jan 10, 2013 · $40K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 35,216 at $56.52 on Jan 10, 2013 · $2M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 117 at $56.52 on Jan 9, 2013 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 5,783 at $56.52 on Jan 9, 2013 · $327K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 72 at $59.34 on Oct 2, 2012 · $4K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,228 at $58.59 on Oct 2, 2012 · $72K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 3,667 at $59.34 on Oct 2, 2012 · $218K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 61,683 at $58.59 on Oct 2, 2012 · $3.6M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 21,615 at $49.56 on Mar 9, 2012 · $1.1M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 1,078,400 at $49.56 on Mar 9, 2012 · $53.4M	Filing · EDGAR
—	—	—	Notice not machine-readable Jazz Pharmaceuticals (JAZZ): Sold 49,985 at $49.56 on Mar 9, 2012 · $2.5M	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 35,574 at $1.50 on Mar 1, 2007 · $53K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 30,000 at $1.48 on Mar 1, 2007 · $44K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 125,000 at $1.46 on Mar 1, 2007 · $183K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 225,000 at $1.45 on Mar 1, 2007 · $326K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 125,000 at $1.55 on Feb 28, 2007 · $194K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 25,000 at $1.53 on Feb 28, 2007 · $38K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 25,000 at $1.53 on Feb 28, 2007 · $38K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 125,000 at $1.52 on Feb 28, 2007 · $190K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 110,000 at $1.51 on Feb 28, 2007 · $166K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 75,000 at $1.51 on Feb 28, 2007 · $113K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 90,000 at $1.50 on Feb 28, 2007 · $135K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 30,000 at $1.50 on Feb 28, 2007 · $45K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 120,000 at $1.50 on Feb 28, 2007 · $180K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 25,000 at $1.49 on Feb 28, 2007 · $37K	Filing · EDGAR
—	—	—	Notice not machine-readable Molecular Templates: Sold 57,003 at $10.46 on Oct 28, 2005 · $596K	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Jazz Pharmaceuticals JAZZ Director · filings 2009 to 2026 · sold $236.8M · bought $8.1M · $1.6M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 31, 2026	Shares withheld for tax or exercise price	−14	$244.64	$3K	22,970 direct	Filing · EDGAR
Aug 31, 2026	Shares withheld for tax or exercise price	−1,692	$241.39	$408K	21,278 direct	Filing · EDGAR
Aug 5, 2026	Grant or award from the company	+1,605			22,984 direct	Filing · EDGAR
Aug 18, 2025	Other acquisition or disposition (see the filing)	−5,000			21,379 direct	Filing · EDGAR
Aug 8, 2025	Shares withheld for tax or exercise price	−1,805	$111.25	$201K	26,379 direct	Filing · EDGAR
Aug 7, 2025	Grant or award from the company	+3,507			28,184 direct	Filing · EDGAR
Aug 2, 2024	Grant or award from the company	+3,731			24,677 direct	Filing · EDGAR
Aug 14, 2023	Open-market or private sale	−1,241	$138.16	$171K	20,946 direct	Filing · EDGAR
Aug 11, 2023	Grant or award from the company	+3,075			22,187 direct	Filing · EDGAR
Nov 22, 2022	Open-market or private sale	−2,905	$149.18	$433K	21,181 direct	Filing · EDGAR
Nov 22, 2022	Open-market or private sale	−2,069	$149.90	$310K	19,112 direct	Filing · EDGAR
Nov 22, 2022	Open-market or private sale	−2,000	$152.88	$306K	0 by Trust	Filing · EDGAR
Aug 8, 2022	Open-market or private sale	−1,089	$152.33	$166K	24,086 direct	Filing · EDGAR
Aug 5, 2022	Grant or award from the company	+2,561			25,175 direct	Filing · EDGAR
Aug 18, 2021	Grant or award from the company	+2,000	$137.75	$276K	2,000 by Trust	Filing · EDGAR
Jul 29, 2021	Grant or award from the company	+2,246			22,614 direct	Filing · EDGAR
Nov 12, 2020	Sale under a 10b5-1 plan	−3,223	$145.81	$470K	27,074 direct	Filing · EDGAR
Nov 12, 2020	Sale under a 10b5-1 plan	−5,083	$147.00	$747K	21,991 direct	Filing · EDGAR
Nov 12, 2020	Sale under a 10b5-1 plan	−1,623	$147.61	$240K	20,368 direct	Filing · EDGAR
Nov 2, 2020	Option or RSU exercised or converted	+9,929			30,297 direct	Filing · EDGAR
Nov 2, 2020	Option or RSU exercised or converted Phantom Stock	−9,929			0 direct	Filing · EDGAR
Aug 6, 2020	Grant or award from the company	+2,705			20,368 direct	Filing · EDGAR
Aug 6, 2020	Grant or award from the company Non-Qualified Stock Option (right to buy)	+6,765			6,765 direct	Filing · EDGAR
Aug 9, 2019	Open-market or private sale	−726	$135.65	$98K	17,663 direct	Filing · EDGAR
Aug 8, 2019	Grant or award from the company	+1,920			18,389 direct	Filing · EDGAR
Aug 8, 2019	Grant or award from the company Non-Qualified Stock Option (right to buy)	+4,805			4,805 direct	Filing · EDGAR
Sep 6, 2018	Option or RSU exercised or converted	+3,415	$143.66	$491K	19,884 direct	Filing · EDGAR
Sep 6, 2018	Option or RSU exercised or converted	+3,415	$138.08	$472K	23,299 direct	Filing · EDGAR
Sep 6, 2018	Option or RSU exercised or converted	+3,300	$135.44	$447K	26,599 direct	Filing · EDGAR
Sep 6, 2018	Sale under a 10b5-1 plan	−2,044	$167.96	$343K	24,555 direct	Filing · EDGAR
Sep 6, 2018	Sale under a 10b5-1 plan	−7,086	$168.86	$1.2M	17,469 direct	Filing · EDGAR
Sep 6, 2018	Sale under a 10b5-1 plan	−1,000	$169.69	$170K	16,469 direct	Filing · EDGAR
Sep 6, 2018	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−3,300			0 direct	Filing · EDGAR
Sep 6, 2018	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−3,415			0 direct	Filing · EDGAR
Sep 6, 2018	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−3,415			0 direct	Filing · EDGAR
Aug 10, 2018	Open-market or private sale	−1,365	$175.13	$239K	16,469 direct	Filing · EDGAR
Aug 9, 2018	Grant or award from the company	+1,495			17,834 direct	Filing · EDGAR
Aug 9, 2018	Grant or award from the company Non-Qualified Stock Option (right to buy)	+3,735			3,735 direct	Filing · EDGAR
Dec 11, 2017	Option or RSU exercised or converted	+4,500	$46.83	$211K	20,839 direct	Filing · EDGAR
Dec 11, 2017	Option or RSU exercised or converted	+4,500	$81.76	$368K	25,339 direct	Filing · EDGAR
Dec 11, 2017	Sale under a 10b5-1 plan	−800	$138.15	$111K	24,539 direct	Filing · EDGAR
Dec 11, 2017	Sale under a 10b5-1 plan	−5,358	$139.56	$748K	19,181 direct	Filing · EDGAR
Dec 11, 2017	Sale under a 10b5-1 plan	−2,842	$140.50	$399K	16,339 direct	Filing · EDGAR
Dec 11, 2017	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−4,500			0 direct	Filing · EDGAR
Dec 11, 2017	Option or RSU exercised or converted Non-employee director stock option	−4,500			0 direct	Filing · EDGAR
Nov 17, 2017	Sale under a 10b5-1 plan	−352	$133.19	$47K	1,365 direct	Filing · EDGAR
Aug 25, 2017	Sale under a 10b5-1 plan	−351	$148.40	$52K	1,717 direct	Filing · EDGAR
Aug 11, 2017	Open-market or private sale	−659	$142.36	$94K	2,071 direct	Filing · EDGAR
Aug 11, 2017	Open-market or private sale	−3	$144.13	$432	2,068 direct	Filing · EDGAR
Aug 10, 2017	Grant or award from the company	+1,365			2,730 direct	Filing · EDGAR
Aug 10, 2017	Grant or award from the company Non-Qualified Stock Option (right to buy)	+3,415			3,415 direct	Filing · EDGAR
Dec 2, 2016	Sale under a 10b5-1 plan	−677	$101.80	$69K	1,365 direct	Filing · EDGAR
Aug 15, 2016	Open-market or private sale	−633	$136.45	$86K	2,042 direct	Filing · EDGAR
Aug 11, 2016	Grant or award from the company	+1,365			2,675 direct	Filing · EDGAR
Aug 11, 2016	Grant or award from the company Non-Qualified Stock Option (right to buy)	+3,415			3,415 direct	Filing · EDGAR
Feb 10, 2016	Open-market or private sale	−294	$114.43	$34K	225,187 By Longitude Venture Partners, L.P.	Filing · EDGAR
Feb 10, 2016	Open-market or private sale	−1,698	$116.20	$197K	223,489 By Longitude Venture Partners, L.P.	Filing · EDGAR
Feb 10, 2016	Open-market or private sale	−2,594	$117.46	$305K	220,895 By Longitude Venture Partners, L.P.	Filing · EDGAR
Feb 10, 2016	Open-market or private sale	−3,159	$118.40	$374K	217,736 By Longitude Venture Partners, L.P.	Filing · EDGAR
Feb 10, 2016	Open-market or private sale	−1,666	$119.55	$199K	216,070 By Longitude Venture Partners, L.P.	Filing · EDGAR

242 earlier transactions are in the filing list below.

Zenas BioPharma ZBIO Director · filings 2024 to 2026 · bought $9.7M

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 15, 2026	Grant or award from the company Stock Option (Right to Buy)	+18,500			18,500 direct	Filing · EDGAR
Oct 9, 2025	Open-market or private purchase	+105,265	$19.00	$2M	1,832,669 See Footnote	Filing · EDGAR
Oct 9, 2025	Open-market or private purchase	+11,990	$20.85	$250K	11,990 direct	Filing · EDGAR
Jun 10, 2025	Grant or award from the company Stock Option (Right to Buy)	+18,500			18,500 direct	Filing · EDGAR
Sep 16, 2024	Derivative converted	+723,812			723,812 See Footnote	Filing · EDGAR
Sep 16, 2024	Derivative converted	+1,003,592			1,727,404 See Footnote	Filing · EDGAR
Sep 16, 2024	Derivative converted	+334,530			334,530 See Footnote	Filing · EDGAR
Sep 16, 2024	Open-market or private purchase	+440,000	$17.00	$7.5M	774,530 See Footnote	Filing · EDGAR
Sep 16, 2024	Derivative converted Series B Convertible Preferred Stock	−6,284,933			0 See Footnote	Filing · EDGAR
Sep 16, 2024	Derivative converted Series C Convertible Preferred Stock	−8,714,293			0 See Footnote	Filing · EDGAR
Sep 16, 2024	Derivative converted Series C Convertible Preferred Stock	−2,904,764			0 See Footnote	Filing · EDGAR
Sep 12, 2024	Grant or award from the company Stock Option (Right to Buy)	+37,000			37,000 direct	Filing · EDGAR

BioAge Labs BIOA Director · filings 2024 to 2026 · bought $7.2M

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 10, 2026	Grant or award from the company Stock Option (Right to Buy)	+22,000			22,000 direct	Filing · EDGAR
Jun 5, 2025	Grant or award from the company Stock Option (Right to Buy)	+22,000			22,000 direct	Filing · EDGAR
Sep 27, 2024	Derivative converted	+1,310,589			1,310,589 Longitude Venture Partners IV, L.P.	Filing · EDGAR
Sep 27, 2024	Open-market or private purchase	+400,000	$18.00	$7.2M	1,710,589 Longitude Venture Partners IV, L.P.	Filing · EDGAR
Sep 27, 2024	Derivative converted Series D Preferred Stock	−5,848,637			0 Longitude Venture Partners IV, L.P.	Filing · EDGAR
Sep 25, 2024	Grant or award from the company Stock Option (Right to Buy)	+15,000			15,000 direct	Filing · EDGAR

Vera Therapeutics VERA Director · filings 2021 to 2026 · bought $32.5M

Date	Transaction	Shares	Price	Value	Held after	Source
May 21, 2026	Grant or award from the company Stock Option (right to buy)	+17,084			17,084 direct	Filing · EDGAR
Dec 11, 2025	Open-market or private purchase	+5,882	$42.50	$250K	5,882 direct	Filing · EDGAR
Jun 24, 2025	Open-market or private purchase	+13,536	$22.35	$303K	1,797,619 See footnote	Filing · EDGAR
Jun 24, 2025	Open-market or private purchase	+27,071	$22.35	$605K	3,596,593 See footnote	Filing · EDGAR
Jun 23, 2025	Open-market or private purchase	+69,798	$20.87	$1.5M	1,784,083 See footnote	Filing · EDGAR
Jun 23, 2025	Open-market or private purchase	+139,595	$20.87	$2.9M	3,569,522 See footnote	Filing · EDGAR
May 14, 2025	Grant or award from the company Stock Option (right to buy)	+14,000			14,000 direct	Filing · EDGAR
May 15, 2024	Grant or award from the company Stock Option (right to buy)	+14,000			14,000 direct	Filing · EDGAR
May 10, 2023	Grant or award from the company Stock Option (right to buy)	+20,000			20,000 direct	Filing · EDGAR
Feb 6, 2023	Open-market or private purchase	+1,714,285	$7.00	$12M	1,714,285 See footnote	Filing · EDGAR
May 24, 2022	Grant or award from the company Stock Option (right to buy)	+9,925			9,925 direct	Filing · EDGAR
Feb 10, 2022	Open-market or private purchase	+333,333	$15.00	$5M	3,429,927 See footnote	Filing · EDGAR
May 18, 2021	Derivative converted	+2,187,504			2,187,504 See footnote	Filing · EDGAR
May 18, 2021	Open-market or private purchase	+909,090	$11.00	$10M	3,096,594 See footnote	Filing · EDGAR
May 18, 2021	Derivative converted Series C Preferred Stock	−2,187,504			0 See footnote	Filing · EDGAR
May 13, 2021	Grant or award from the company Stock Option (right to buy)	+9,925			9,925 direct	Filing · EDGAR

Rapid Micro Biosystems RPID 10% owner · filings 2021 to 2026 · sold $664K · bought $3M

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 4, 2026	Open-market or private sale	−49,000	$3.88	$190K	0 Held by Longitude Prime Fund, L.P.	Filing · EDGAR
Feb 3, 2026	Open-market or private sale	−27,500	$4.24	$117K	49,000 Held by Longitude Prime Fund, L.P.	Filing · EDGAR
Feb 2, 2026	Open-market or private sale	−27,500	$4.25	$117K	76,500 Held by Longitude Prime Fund, L.P.	Filing · EDGAR
Jan 30, 2026	Open-market or private sale	−46,000	$4.54	$209K	104,000 Held by Longitude Prime Fund, L.P.	Filing · EDGAR
Jan 23, 2026	In-the-money option exercised	+629,032	$0.05	$31K	4,036,984 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jan 23, 2026	Open-market or private sale	−7,739	$4.06	$31K	4,029,245 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jan 23, 2026	In-the-money option exercised Class A Common Stock	−500,000			0 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jan 23, 2026	In-the-money option exercised Class A Common Stock	−129,032			0 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted	+3,344,038			3,407,952 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Open-market or private purchase	+150,000	$20.00	$3M	150,000 Held by Longitude Prime Fund, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted Series A1 Preferred Stock	−8,774,007			0 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted Series B1 Preferred Stock	−5,654,529			0 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted Series C1 Preferred Stock	−2,291,665			0 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted Series A1 Warrant	−2,500,000			0 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted Common Stock Warrant	+500,000			500,000 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted Series B1 Warrant	−645,160			0 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 19, 2021	Derivative converted Common Stock Warrant	+129,032			129,032 Held by Longitude Venture Partners II, L.P.	Filing · EDGAR

Veradermics MANE Director, 10% owner · filings 2026 to 2026 · bought $18.3M

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 5, 2026	Derivative converted	+1,236,631	$0.00	$12	1,236,631 See Footnote	Filing · EDGAR
Feb 5, 2026	Derivative converted	+1,171,121			2,407,752 See Footnote	Filing · EDGAR
Feb 5, 2026	Derivative converted	+1,171,121			1,171,121 See Footnote	Filing · EDGAR
Feb 5, 2026	Open-market or private purchase	+192,647	$17.00	$3.3M	2,600,399 See Footnote	Filing · EDGAR
Feb 5, 2026	Open-market or private purchase	+882,353	$17.00	$15M	2,053,474 See Footnote	Filing · EDGAR
Feb 5, 2026	Derivative converted Series B Convertible Preferred Stock	−1,236,631			0 See Footnote	Filing · EDGAR
Feb 5, 2026	Derivative converted Series C Convertible Preferred Stock	−1,171,121			0 See Footnote	Filing · EDGAR
Feb 5, 2026	Derivative converted Series C Convertible Preferred Stock	−1,171,121			0 See Footnote	Filing · EDGAR
Feb 3, 2026	Grant or award from the company Stock Option (Right to Buy)	+45,131			45,131 direct	Filing · EDGAR

Lexeo Therapeutics 10% owner · filings 2023 to 2023 · bought $5M

Date	Transaction	Shares	Price	Value	Held after	Source
Nov 7, 2023	Derivative converted	+1,793,429			1,793,429 By Longitude Venture Partners IV, L.P.	Filing · EDGAR
Nov 7, 2023	Derivative converted	+319,126			2,112,555 By Longitude Venture Partners IV, L.P.	Filing · EDGAR
Nov 7, 2023	Open-market or private purchase	+454,545	$11.00	$5M	2,567,100 By Longitude Venture Partners IV, L.P.	Filing · EDGAR
Nov 7, 2023	Derivative converted Series A convertible preferred stock	−18,999,999			0 By Longitude Venture Partners IV, L.P.	Filing · EDGAR
Nov 7, 2023	Derivative converted Series B convertible preferred stock	−2,906,148			0 By Longitude Venture Partners IV, L.P.	Filing · EDGAR

Aptinyx Director · filings 2018 to 2022 · bought $3.2M

Date	Transaction	Shares	Price	Value	Held after	Source
May 26, 2022	Grant or award from the company Stock Option (Right to Buy)	+40,000			40,000 direct	Filing · EDGAR
May 27, 2021	Grant or award from the company Stock Option (Right to Buy)	+40,000			40,000 direct	Filing · EDGAR
Dec 31, 2020	Grant or award from the company Stock Option (Right to Buy)	+8,149	$2.22	$18K	8,149 direct	Filing · EDGAR
Sep 30, 2020	Grant or award from the company Stock Option (Right to Buy)	+8,379	$2.16	$18K	8,379 direct	Filing · EDGAR
Jun 30, 2020	Grant or award from the company Stock Option (Right to Buy)	+5,436	$2.68	$15K	5,436 direct	Filing · EDGAR
May 20, 2020	Grant or award from the company Stock Option (Right to Buy)	+40,000			40,000 direct	Filing · EDGAR
Mar 31, 2020	Grant or award from the company Stock Option (Right to Buy)	+8,573	$1.36	$12K	8,573 direct	Filing · EDGAR
Jan 10, 2020	Open-market or private purchase	+95,000	$3.00	$285K	95,000 direct	Filing · EDGAR
Jan 10, 2020	Open-market or private purchase	+166,667	$3.00	$500K	3,356,746 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Dec 31, 2019	Grant or award from the company Stock Option (Right to Buy)	+5,427	$2.14	$12K	5,427 direct	Filing · EDGAR
Sep 30, 2019	Grant or award from the company Stock Option (Right to Buy)	+5,582	$2.08	$12K	5,582 direct	Filing · EDGAR
Jun 28, 2019	Grant or award from the company Stock Option (Right to Buy)	+5,866	$1.98	$12K	5,866 direct	Filing · EDGAR
May 15, 2019	Grant or award from the company Stock Option (Right to Buy)	+40,000			40,000 direct	Filing · EDGAR
Mar 29, 2019	Grant or award from the company Stock Option (Right to Buy)	+4,793	$2.43	$12K	4,793 direct	Filing · EDGAR
Jun 25, 2018	Derivative converted	+1,047,450			1,047,450 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Jun 25, 2018	Derivative converted	+1,197,076			2,244,526 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Jun 25, 2018	Derivative converted	+795,553			3,040,079 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Jun 25, 2018	Open-market or private purchase	+150,000	$16.00	$2.4M	3,190,079 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Jun 25, 2018	Derivative converted Series A-1 Convertible Preferred Stock	−28,895,188			0 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Jun 25, 2018	Derivative converted Series A-2 Convertible Preferred Stock	−33,022,786			0 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Jun 25, 2018	Derivative converted Series B Convertible Preferred Stock	−21,946,301			0 By: Longitude Venture Partners II, L.P.	Filing · EDGAR

Sierra Oncology 10% owner · filings 2019 to 2022 · bought $4.7M

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 27, 2022	Other acquisition or disposition (see the filing)	−175,000			0 See footnote	Filing · EDGAR
Apr 27, 2022	Other acquisition or disposition (see the filing)	−1,964,771			0 See footnote	Filing · EDGAR
Apr 27, 2022	Other acquisition or disposition (see the filing)	+5,023			5,023 See footnote	Filing · EDGAR
Apr 27, 2022	Other acquisition or disposition (see the filing)	+2,152			2,152 See footnote	Filing · EDGAR
Apr 27, 2022	Other acquisition or disposition (see the filing)	+7,175			7,175 See footnote	Filing · EDGAR
Apr 27, 2022	Other acquisition or disposition (see the filing)	+588			5,611 See footnote	Filing · EDGAR
Apr 27, 2022	Other acquisition or disposition (see the filing)	+252			2,404 See footnote	Filing · EDGAR
Apr 27, 2022	Other acquisition or disposition (see the filing)	+840			8,015 See footnote	Filing · EDGAR
Feb 2, 2022	Open-market or private purchase	+175,000	$27.00	$4.7M	175,000 See footnote	Filing · EDGAR
Jan 25, 2022	In-the-money option exercised	+487,451	$13.20	$6.4M	1,964,771 See footnote	Filing · EDGAR
Jan 25, 2022	In-the-money option exercised Series B Warrants	−1,477,125	$13.20	$19.5M	0 See footnote	Filing · EDGAR
Jan 29, 2020	Derivative converted	+1,477,320			1,477,320 See Footnote	Filing · EDGAR
Jan 29, 2020	Derivative converted Series A Convertible Voting Preferred Stock	−19,500			0 See Footnote	Filing · EDGAR

Inozyme Pharma 10% owner · filings 2020 to 2022 · bought $15M

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 19, 2022	Open-market or private purchase	+1,355,000	$3.69	$5M	4,174,379 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Jul 28, 2020	Derivative converted	+2,007,225			2,007,225 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Jul 28, 2020	Derivative converted	+187,154			2,194,379 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Jul 28, 2020	Open-market or private purchase	+625,000	$16.00	$10M	2,819,379 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Jul 28, 2020	Derivative converted Series A Convertible Preferred Stock	−15,000,000			0 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Jul 28, 2020	Derivative converted Series A-2 Convertible Preferred Stock	−1,398,600			0 By Longitude Venture Partners III, L.P.	Filing · EDGAR

Talaris Therapeutics 10% owner · filings 2021 to 2021 · bought $4M

Date	Transaction	Shares	Price	Value	Held after	Source
May 11, 2021	Derivative converted	+2,985,775			2,985,775 By Longitude Venture Partners III, L.P.	Filing · EDGAR
May 11, 2021	Open-market or private purchase	+235,000	$17.00	$4M	3,220,775 By Longitude Venture Partners III, L.P.	Filing · EDGAR
May 11, 2021	Derivative converted Series A Preferred Stock	−1,308,410			0 By Longitude Venture Partners III, L.P.	Filing · EDGAR
May 11, 2021	Derivative converted Series A-1 Preferred Stock	−1,271,027			0 By Longitude Venture Partners III, L.P.	Filing · EDGAR
May 11, 2021	Derivative converted Series B Preferred Stock	−406,338			0 By Longitude Venture Partners III, L.P.	Filing · EDGAR

Eargo 10% owner · filings 2020 to 2021 · bought $4.2M

Date	Transaction	Shares	Price	Value	Held after	Source
Apr 14, 2021	Other acquisition or disposition (see the filing)	−1,000,000			2,918,691 direct	Filing · EDGAR
Apr 14, 2021	Other acquisition or disposition (see the filing)	+5,012			5,012 See Footnote	Filing · EDGAR
Oct 20, 2020	Derivative converted	+3,685,358			3,685,358 direct	Filing · EDGAR
Oct 20, 2020	Open-market or private purchase	+233,333	$18.00	$4.2M	3,918,691 direct	Filing · EDGAR
Oct 20, 2020	Derivative converted Series E Preferred Stock	−3,685,358			0 direct	Filing · EDGAR

89bio 10% owner · filings 2019 to 2020 · bought $12.2M

Date	Transaction	Shares	Price	Value	Held after	Source
Nov 16, 2020	Other acquisition or disposition (see the filing)	−850,000			1,750,877 See footnote	Filing · EDGAR
Nov 16, 2020	Other acquisition or disposition (see the filing)	+2,973			2,973 See footnote	Filing · EDGAR
Nov 16, 2020	Other acquisition or disposition (see the filing)	+2,080			2,080 See footnote	Filing · EDGAR
Nov 16, 2020	Other acquisition or disposition (see the filing)	+891			891 See footnote	Filing · EDGAR
Jul 10, 2020	Open-market or private purchase	+109,090	$27.50	$3M	2,600,877 See footnote	Filing · EDGAR
Nov 13, 2019	Derivative converted	+1,916,787			2,491,787 See footnote	Filing · EDGAR
Nov 13, 2019	Derivative converted Series A Preferred Stock	−11,916,667			0 See footnote	Filing · EDGAR
Nov 11, 2019	Open-market or private purchase	+575,000	$16.00	$9.2M	575,000 See footnote	Filing · EDGAR

Aimmune Therapeutics Director · filings 2015 to 2020 · bought $14.1M

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 13, 2020	Returned to the company	−7,840	$34.50	$270K	0 direct	Filing · EDGAR
Oct 13, 2020	Returned to the company Stock Option (right to buy)	−65,849	$34.36	$2.3M	0 direct	Filing · EDGAR
Oct 13, 2020	Returned to the company Stock Option (right to buy)	−52,421	$28.21	$1.5M	0 direct	Filing · EDGAR
Oct 13, 2020	Returned to the company Stock Option (right to buy)	−19,755	$19.10	$377K	0 direct	Filing · EDGAR
Oct 13, 2020	Returned to the company Stock Option (right to buy)	−17,500	$16.24	$284K	0 direct	Filing · EDGAR
Oct 13, 2020	Returned to the company Stock Option (right to buy)	−7,500	$1.71	$13K	0 direct	Filing · EDGAR
Oct 13, 2020	Returned to the company Stock Option (right to buy)	−11,432	$14.60	$167K	0 direct	Filing · EDGAR
Oct 13, 2020	Returned to the company Stock Option (right to buy)	−15,398	$17.39	$268K	0 direct	Filing · EDGAR
Oct 10, 2020	Tendered in a change of control	−70,561	$34.50	$2.4M	0 direct	Filing · EDGAR
Oct 10, 2020	Tendered in a change of control	−91,697	$34.50	$3.2M	0 By: LCP2	Filing · EDGAR
Sep 21, 2020	Other acquisition or disposition (see the filing)	−6,113,134			0 By: LVP2	Filing · EDGAR
Sep 21, 2020	Other acquisition or disposition (see the filing)	+91,697			91,697 By: LCP2	Filing · EDGAR
May 27, 2020	Open-market or private sale	+7,840			78,401 direct	Filing · EDGAR
May 27, 2020	Grant or award from the company Stock Option (right to buy)	+15,398			15,398 direct	Filing · EDGAR
Mar 18, 2020	Open-market or private purchase	+16,213	$11.06	$179K	70,561 direct	Filing · EDGAR
Mar 17, 2020	Open-market or private purchase	+100,000	$11.40	$1.1M	6,113,134 By: LVP2	Filing · EDGAR
Mar 17, 2020	Open-market or private purchase	+8,787	$11.50	$101K	54,348 direct	Filing · EDGAR
Sep 17, 2019	Grant or award from the company	+12,500	$22.34	$279K	45,561 direct	Filing · EDGAR
May 23, 2019	Grant or award from the company	+6,442			33,061 direct	Filing · EDGAR
May 23, 2019	Grant or award from the company Stock Option (right to buy)	+11,432			11,432 direct	Filing · EDGAR
May 23, 2018	Grant or award from the company	+3,750			26,619 direct	Filing · EDGAR
May 23, 2018	Grant or award from the company Stock Option (right to buy)	+7,500			7,500 direct	Filing · EDGAR
Feb 22, 2018	Open-market or private purchase	+15,593	$32.00	$499K	22,869 direct	Filing · EDGAR
May 25, 2017	Grant or award from the company Stock Option (right to buy)	+17,500			17,500 direct	Filing · EDGAR
Nov 29, 2016	Other acquisition or disposition (see the filing)	−1,500,000			6,013,134 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Nov 29, 2016	Other acquisition or disposition (see the filing)	+7,276			7,276 direct	Filing · EDGAR
May 25, 2016	Grant or award from the company Stock Option (right to buy)	+19,755			19,755 direct	Filing · EDGAR
Mar 29, 2016	Open-market or private purchase	+33,064	$13.50	$446K	7,467,694 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Mar 29, 2016	Open-market or private purchase	+45,440	$14.15	$643K	7,513,134 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Mar 29, 2016	Open-market or private purchase	+33,064	$13.50	$446K	7,467,694 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Mar 29, 2016	Open-market or private purchase	+45,440	$14.15	$643K	7,513,134 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted	+3,873,530			3,873,530 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted	+3,248,600			7,122,130 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Open-market or private purchase	+312,500	$16.00	$5M	7,434,630 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted Series A Convertible Preferred Stock	−3,873,530			0 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted Series B Convertible Preferred Stock	−3,248,600			0 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted	+3,873,530			3,873,530 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted	+3,248,600			7,122,130 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Open-market or private purchase	+312,500	$16.00	$5M	7,434,630 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted Series A Convertible Preferred Stock	−3,873,530			0 By: Longitude Venture Partners II, L.P.	Filing · EDGAR
Aug 11, 2015	Derivative converted Series B Convertible Preferred Stock	−3,248,600			0 By: Longitude Venture Partners II, L.P.	Filing · EDGAR

Molecular Templates 10% owner · filings 2005 to 2020 · sold $2.4M · bought $11.2M

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 28, 2020	Open-market or private sale	−2,447	$10.75	$26K	0 See Footnote	Filing · EDGAR
Aug 28, 2020	Open-market or private sale	−1,049	$10.75	$11K	0 See Footnote	Filing · EDGAR
May 26, 2020	Other acquisition or disposition (see the filing)	−1,000,000			3,199,035 By Longitude Venture Partners III, L.P.	Filing · EDGAR
May 26, 2020	Other acquisition or disposition (see the filing)	+3,495			3,495 See Footnote	Filing · EDGAR
May 26, 2020	Other acquisition or disposition (see the filing)	+2,447			2,447 See Footnote	Filing · EDGAR
May 26, 2020	Other acquisition or disposition (see the filing)	+1,049			1,049 See Footnote	Filing · EDGAR
Nov 25, 2019	Open-market or private purchase	+937,500	$8.00	$7.5M	4,199,035 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Sep 21, 2018	Open-market or private purchase	+365,000	$5.50	$2M	3,261,535 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Mar 1, 2007	Open-market or private sale	−225,000	$1.45	$326K	190,574 Investment Advisor	Filing · EDGAR
Mar 1, 2007	Open-market or private sale	−125,000	$1.46	$183K	65,574 Investment Advisor	Filing · EDGAR
Mar 1, 2007	Open-market or private sale	−30,000	$1.48	$44K	35,574 Investment Advisor	Filing · EDGAR
Mar 1, 2007	Open-market or private sale	−35,574	$1.50	$53K	0 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−25,000	$1.49	$37K	1,140,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−120,000	$1.50	$180K	1,020,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−30,000	$1.50	$45K	990,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−90,000	$1.50	$135K	900,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−75,000	$1.51	$113K	825,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−110,000	$1.51	$166K	715,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−125,000	$1.52	$190K	590,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−25,000	$1.53	$38K	565,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−25,000	$1.53	$38K	540,574 Investment Advisor	Filing · EDGAR
Feb 28, 2007	Open-market or private sale	−125,000	$1.55	$194K	415,574 Investment Advisor	Filing · EDGAR
Sep 29, 2006	Grant or award from the company Stock Option (Right-to-buy)	+15,000			15,000 Investment Advisor	Filing · EDGAR
Sep 29, 2006	Grant or award from the company Stock Option (Right-to-buy)	+15,000			15,000 Investment Advisor	Filing · EDGAR
Sep 27, 2006	Grant or award from the company Stock Option (Right-to-buy)	+15,000			15,000 Investment Advisor	Filing · EDGAR
Sep 27, 2006	Grant or award from the company Stock Option (Right-to-buy)	+15,000			15,000 Investment Advisor	Filing · EDGAR
Sep 25, 2006	Returned to the company Stock Option (Right-to-buy)	−15,000			0 Investment Advisor	Filing · EDGAR
Sep 25, 2006	Returned to the company Stock Option (Right-to-buy)	−15,000			0 Investment Advisor	Filing · EDGAR
May 25, 2006	Grant or award from the company Stock Option (Right-to-buy)	+15,000			15,000 Investment Advisor	Filing · EDGAR
Apr 20, 2006	Other acquisition or disposition (see the filing)	−1,165,574			1,165,574 Investment Advisor	Filing · EDGAR
Apr 20, 2006	Other acquisition or disposition (see the filing)	+248			496 direct	Filing · EDGAR
Mar 3, 2006	Other acquisition or disposition (see the filing)	−1,165,574			2,331,148 Investment Advisor	Filing · EDGAR
Mar 3, 2006	Other acquisition or disposition (see the filing)	+248			248 direct	Filing · EDGAR
Oct 28, 2005	Open-market or private sale	−57,003	$10.46	$596K	3,496,722 Investment Advisor	Filing · EDGAR
May 19, 2005	Grant or award from the company Stock Option (Right-to-buy	+15,000			15,000 Investment Advisor	Filing · EDGAR
Feb 9, 2005	Open-market or private purchase	+241,719	$7.00	$1.7M	0 Investment Advisor	Filing · EDGAR
Feb 9, 2005	Derivative converted	+3,312,006			3,553,725 Investment Advisor	Filing · EDGAR
Feb 9, 2005	Derivative converted Series B Preferred Stock	−3,312,006			0 Investment Adviser	Filing · EDGAR

Vaxcyte 10% owner · filings 2020 to 2020

No transactions in the filings read; Form 144 notices are listed above.

Venus Concept 10% owner · filings 2019 to 2019

No transactions in the filings read; Form 144 notices are listed above.

Axonics Modulation Technologies 10% owner · filings 2018 to 2018 · bought $8M

Date	Transaction	Shares	Price	Value	Held after	Source
Nov 2, 2018	Derivative converted	+2,400,000			2,400,000 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Nov 2, 2018	Open-market or private purchase	+533,333	$15.00	$8M	2,933,333 By Longitude Venture Partners III, L.P.	Filing · EDGAR
Nov 2, 2018	Derivative converted Series C Preferred Stock	−2,000,000			0 By Longitude Venture Partners III, L.P.	Filing · EDGAR

Tricida 10% owner · filings 2018 to 2018 · bought $2.5M

Date	Transaction	Shares	Price	Value	Held after	Source
Jul 2, 2018	Derivative converted	+2,431,511			2,431,511 Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 2, 2018	Derivative converted	+456,644			2,888,155 Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 2, 2018	Open-market or private purchase	+131,579	$19.00	$2.5M	3,019,734 Longitude Venture Partners II, L.P	Filing · EDGAR
Jul 2, 2018	Derivative converted Series C Convertible Preferred Stock	−9,677,419			0 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 2, 2018	Derivative converted Series D Convertible Preferred Stock	−1,817,447			0 By Longitude Venture Partners II, L.P.	Filing · EDGAR

Collegium Pharmaceutical 10% owner · filings 2015 to 2017 · sold $17.3M · bought $2.4M

Date	Transaction	Shares	Price	Value	Held after	Source
Dec 8, 2017	Open-market or private sale	−980,350	$17.34	$17M	2,276,222 By LVP	Filing · EDGAR
Dec 8, 2017	Open-market or private sale	−19,650	$17.34	$341K	45,620 By LCA	Filing · EDGAR
May 12, 2015	Derivative converted	+3,060,502			3,060,502 By Longitude Venture Partners, L.P.	Filing · EDGAR
May 12, 2015	Open-market or private purchase	+196,070	$12.00	$2.4M	3,256,572 By Longitude Venture Partners, L.P.	Filing · EDGAR
May 12, 2015	Derivative converted	+61,340			61,340 By Longitude Capital Associates, L.P.	Filing · EDGAR
May 12, 2015	Open-market or private purchase	+3,930	$12.00	$47K	65,270 By Longitude Capital Associates, L.P.	Filing · EDGAR
May 12, 2015	Derivative converted Series B Convertible Preferred Stock	−12,837,935			0 By Longitude Venture Partners, L.P.	Filing · EDGAR
May 12, 2015	Derivative converted Series B Convertible Preferred Stock	−257,303			0 By Longitude Capital Associates, L.P.	Filing · EDGAR
May 12, 2015	Derivative converted Series C Convertible Preferred Stock	−3,160,905			0 By Longitude Venture Partners, L.P.	Filing · EDGAR
May 12, 2015	Derivative converted Series C Convertible Preferred Stock	−63,356			0 By Longitude Capital Associates, L.P.	Filing · EDGAR
May 12, 2015	Derivative converted Series D Convertible Preferred Stock	−5,045,381			0 By Longitude Venture Partners, L.P.	Filing · EDGAR
May 12, 2015	Derivative converted Series D Convertible Preferred Stock	−101,128			0 By Longitude Capital Associates, L.P.	Filing · EDGAR

Kala Pharmaceuticals 10% owner · filings 2017 to 2017 · bought $3.2M

Date	Transaction	Shares	Price	Value	Held after	Source
Jul 25, 2017	Derivative converted	+2,055,946			2,055,946 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 25, 2017	Open-market or private purchase	+215,000	$15.00	$3.2M	2,270,946 By Longitude Venture Partners II, L.P.	Filing · EDGAR
Jul 25, 2017	Derivative converted Series C Preferred Stock	−10,707,985			0 By Longitude Venture Partners II, L.P.	Filing · EDGAR

Corcept Therapeutics Director · filings 2008 to 2017 · sold $54.7M · bought $9.5M

Date	Transaction	Shares	Price	Value	Held after	Source
Mar 16, 2017	Open-market or private sale	−264,650	$9.94	$2.6M	5,721,372 By LVP	Filing · EDGAR
Mar 16, 2017	Open-market or private sale	−5,305	$9.94	$53K	114,675 By LCA	Filing · EDGAR
Mar 15, 2017	Open-market or private sale	−273,537	$10.24	$2.8M	6,966,372 By LVP	Filing · EDGAR
Mar 15, 2017	Open-market or private sale	−5,483	$10.24	$56K	139,630 By LCA	Filing · EDGAR
Mar 14, 2017	Open-market or private sale	−294,105	$10.01	$2.9M	7,239,909 By LVP	Filing · EDGAR
Mar 14, 2017	Open-market or private sale	−5,895	$10.01	$59K	145,113 By LCA	Filing · EDGAR
Mar 13, 2017	Open-market or private sale	−20,568	$11.13	$229K	7,534,014 By LVP	Filing · EDGAR
Mar 13, 2017	Open-market or private sale	−412	$11.13	$5K	151,008 By LCA	Filing · EDGAR
Mar 8, 2017	Open-market or private sale	−735,263	$9.75	$7.2M	7,554,582 By LVP	Filing · EDGAR
Mar 8, 2017	Open-market or private sale	−14,737	$9.75	$144K	151,420 By LCA	Filing · EDGAR
Feb 27, 2017	Open-market or private sale	−980,350	$9.05	$8.9M	8,289,845 By LVP	Filing · EDGAR
Feb 27, 2017	Open-market or private sale	−19,650	$9.05	$178K	166,157 By LCA	Filing · EDGAR
Feb 23, 2017	Open-market or private sale	−1,470,525	$8.65	$12.7M	9,270,195 By LVP	Filing · EDGAR
Feb 23, 2017	Open-market or private sale	−29,475	$8.65	$255K	185,807 By LCA	Filing · EDGAR
Dec 12, 2016	Other acquisition or disposition (see the filing)	+204,210			204,210 direct	Filing · EDGAR
Nov 28, 2016	Other acquisition or disposition (see the filing)	−2,941,050			10,834,849 By LVP	Filing · EDGAR
Nov 28, 2016	Other acquisition or disposition (see the filing)	−58,950			121,153 By LCA	Filing · EDGAR
Nov 25, 2016	Open-market or private sale	−14,451	$9.39	$136K	13,775,899 By LVP	Filing · EDGAR
Nov 25, 2016	Open-market or private sale	−290	$9.39	$3K	180,103 By LCA	Filing · EDGAR
Nov 23, 2016	Open-market or private sale	−12,352	$9.30	$115K	13,790,350 By LVP	Filing · EDGAR
Nov 23, 2016	Open-market or private sale	−248	$9.30	$2K	180,393 By LCA	Filing · EDGAR
Nov 22, 2016	Open-market or private sale	−9,411	$9.33	$88K	13,802,702 By LVP	Filing · EDGAR
Nov 22, 2016	Open-market or private sale	−189	$9.33	$2K	180,641 By LCA	Filing · EDGAR
Nov 21, 2016	Open-market or private sale	−116,058	$9.39	$1.1M	13,812,113 By LVP	Filing · EDGAR
Nov 21, 2016	Open-market or private sale	−2,327	$9.39	$22K	180,830 By LCA	Filing · EDGAR
Nov 18, 2016	Open-market or private sale	−98,586	$9.47	$934K	13,928,171 By LVP	Filing · EDGAR
Nov 18, 2016	Open-market or private sale	−1,976	$9.47	$19K	183,157 By LCA	Filing · EDGAR
Nov 17, 2016	Open-market or private sale	−318,764	$9.64	$3.1M	14,026,757 By LVP	Filing · EDGAR
Nov 17, 2016	Open-market or private sale	−6,389	$9.64	$62K	185,133 By LCA	Filing · EDGAR
Nov 16, 2016	Open-market or private sale	−17,052	$9.51	$162K	14,345,521 By LVP	Filing · EDGAR
Nov 16, 2016	Open-market or private sale	−342	$9.51	$3K	191,522 By LCA	Filing · EDGAR
Nov 15, 2016	Open-market or private sale	−154,359	$9.55	$1.5M	14,362,573 By LVP	Filing · EDGAR
Nov 15, 2016	Open-market or private sale	−3,094	$9.55	$30K	191,864 By LCA	Filing · EDGAR
Jul 21, 2016	Grant or award from the company Stock Option (Right to Buy)	+30,000			30,000 direct	Filing · EDGAR
Jun 18, 2015	Grant or award from the company Stock Option (Right to Buy)	+30,000			30,000 direct	Filing · EDGAR
Mar 30, 2015	In-the-money option exercised	+839,811	$4.05	$3.4M	14,516,932 By LVP	Filing · EDGAR
Mar 30, 2015	In-the-money option exercised	+16,833	$4.05	$68K	194,958 By LCA	Filing · EDGAR
Mar 30, 2015	In-the-money option exercised Warrant (Right to Buy)	−839,811			0 By LVP	Filing · EDGAR
Mar 30, 2015	In-the-money option exercised Warrant (Right to Buy)	−16,833			0 By LCA	Filing · EDGAR
Mar 24, 2015	In-the-money option exercised	+1,130,709	$2.77	$3.1M	14,231,469 By LVP	Filing · EDGAR
Mar 24, 2015	Open-market or private sale	−554,348	$5.65	$3.1M	13,677,121 By LVP	Filing · EDGAR
Mar 24, 2015	In-the-money option exercised Warrant (Right to Buy)	−1,130,709			0 By LVP	Filing · EDGAR
Mar 20, 2015	In-the-money option exercised	+634,516	$2.77	$1.8M	13,145,097 By LVP	Filing · EDGAR
Mar 20, 2015	Open-market or private sale	−300,447	$5.85	$1.8M	12,844,650 By LVP	Filing · EDGAR
Mar 20, 2015	In-the-money option exercised	+486,443	$2.77	$1.3M	13,331,093 By LVP	Filing · EDGAR
Mar 20, 2015	Open-market or private sale	−230,333	$5.85	$1.3M	13,100,760 By LVP	Filing · EDGAR
Mar 20, 2015	In-the-money option exercised	+9,750	$2.77	$27K	182,742 By LCA	Filing · EDGAR
Mar 20, 2015	Open-market or private sale	−4,617	$5.85	$27K	178,125 By LCA	Filing · EDGAR
Mar 20, 2015	In-the-money option exercised Warrant (Right to Buy)	−634,516			1,130,709 By LVP	Filing · EDGAR
Mar 20, 2015	In-the-money option exercised Warrant (Right to Buy)	−486,443			0 By LVP	Filing · EDGAR
Mar 20, 2015	In-the-money option exercised Warrant (Right to Buy)	−9,750			0 By LCA	Filing · EDGAR
May 8, 2014	Grant or award from the company Stock Options (right to buy)	+30,000			30,000 direct	Filing · EDGAR
May 2, 2014	Open-market or private sale	−84,744	$4.07	$345K	12,510,581 By Longitude Venture Partners, L.P.	Filing · EDGAR
May 2, 2014	Open-market or private sale	−1,699	$4.07	$7K	172,992 By Longitude Capital Associates, L.P.	Filing · EDGAR
May 1, 2014	Open-market or private sale	−160,343	$4.12	$661K	12,595,325 By Longitude Venture Partners, L.P.	Filing · EDGAR
May 1, 2014	Open-market or private sale	−3,214	$4.12	$13K	174,691 By Longitude Capital Associates, L.P.	Filing · EDGAR
Apr 1, 2014	Open-market or private sale	−245,088	$4.28	$1M	12,755,668 By Longitude Venture Partners, L.P.	Filing · EDGAR
Apr 1, 2014	Open-market or private sale	−4,912	$4.28	$21K	177,905 By Longitude Capital Associates, L.P.	Filing · EDGAR
Mar 7, 2014	Open-market or private sale	−10,225	$4.00	$41K	13,000,756 By Longitude Venture Partners, L.P.	Filing · EDGAR
Mar 7, 2014	Open-market or private sale	−205	$4.00	$820	182,817 By Longitude Capital Associates, L.P.	Filing · EDGAR

22 earlier transactions are in the filing list below.

Esperion Therapeutics Director · filings 2013 to 2015 · sold $72.2M · bought $3M

Date	Transaction	Shares	Price	Value	Held after	Source
May 14, 2015	Grant or award from the company Stock Option (right to buy)	+8,000			8,000 direct	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−283,601	$110.01	$31.2M	1,122,609 By LVP	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−3,353	$111.06	$372K	1,119,256 By LVP	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−194,988	$113.92	$22.2M	924,268 By LVP	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−2,156	$114.15	$246K	922,112 By LVP	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−6,077	$116.05	$705K	916,035 By LVP	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−5,684	$110.01	$625K	22,502 By LCA	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−67	$111.06	$7K	22,435 By LCA	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−3,907	$113.92	$445K	18,528 By LCA	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−44	$114.15	$5K	18,484 By LCA	Filing · EDGAR
Mar 19, 2015	Open-market or private sale	−123	$116.05	$14K	18,361 By LCA	Filing · EDGAR
Nov 18, 2014	Open-market or private sale	−4,592	$31.56	$145K	1,406,622 By LVP	Filing · EDGAR
Nov 18, 2014	Open-market or private sale	−412	$32.14	$13K	1,406,210 By LVP	Filing · EDGAR
Nov 18, 2014	Open-market or private sale	−92	$31.57	$3K	28,194 By LCA	Filing · EDGAR
Nov 18, 2014	Open-market or private sale	−8	$32.13	$257	28,186 By LCA	Filing · EDGAR
Nov 17, 2014	Open-market or private sale	−200,591	$32.01	$6.4M	1,683,178 By LVP	Filing · EDGAR
Nov 17, 2014	Open-market or private sale	−136,148	$32.93	$4.5M	1,547,030 By LVP	Filing · EDGAR
Nov 17, 2014	Open-market or private sale	−135,816	$33.79	$4.6M	1,411,214 By LVP	Filing · EDGAR
Nov 17, 2014	Open-market or private sale	−4,021	$32.01	$129K	33,736 By LCA	Filing · EDGAR
Nov 17, 2014	Open-market or private sale	−2,728	$32.93	$90K	31,008 By LCA	Filing · EDGAR
Nov 17, 2014	Open-market or private sale	−2,722	$33.79	$92K	28,286 By LCA	Filing · EDGAR
Oct 9, 2014	Open-market or private sale	−924	$30.00	$28K	1,883,769 By LVP	Filing · EDGAR
Oct 9, 2014	Open-market or private sale	−19	$30.00	$570	37,757 By LCA	Filing · EDGAR
Oct 7, 2014	Open-market or private sale	−11,692	$30.04	$351K	1,884,693 By LVP	Filing · EDGAR
Oct 7, 2014	Open-market or private sale	−235	$30.04	$7K	37,776 By LCA	Filing · EDGAR
May 15, 2014	Grant or award from the company Stock Option (right to buy)	+5,000			5,000 direct	Filing · EDGAR
Jul 1, 2013	Derivative converted	+1,683,967			1,683,967 By Longitude Venture Partners, L.P.	Filing · EDGAR
Jul 1, 2013	Derivative converted	+33,753			33,753 By Longitude Capital Associates, L.P.	Filing · EDGAR
Jul 1, 2013	Open-market or private purchase	+212,418	$14.00	$3M	1,896,385 By Longitude Venture Partners, L.P.	Filing · EDGAR
Jul 1, 2013	Open-market or private purchase	+4,258	$14.00	$60K	38,011 By Longitude Capital Associates, L.P.	Filing · EDGAR
Jul 1, 2013	Derivative converted Series A Preferred Stock	−1,683,967			0 By Longitude Venture Partners, L.P.	Filing · EDGAR
Jul 1, 2013	Derivative converted Series A Preferred Stock	−33,753			0 By Longitude Capital Associates, L.P.	Filing · EDGAR
Jul 1, 2013	Grant or award from the company Stock Option (right to buy)	+21,471			21,471 direct	Filing · EDGAR

Sequenom Director · filings 2006 to 2007

Date	Transaction	Shares	Held after	Source
Jun 22, 2007	Grant or award from the company Stock Option (Right-to-buy)	+20,000	20,000 Investment Advisor	Filing · EDGAR
Dec 7, 2006	Other acquisition or disposition (see the filing)	−3,333,333	3,333,333 Investment Advisor	Filing · EDGAR
Dec 7, 2006	Other acquisition or disposition (see the filing)	+771	771 direct	Filing · EDGAR
Jun 6, 2006	Grant or award from the company Stock Option (Right-to-buy)	+40,000	40,000 Investment Advisor	Filing · EDGAR

Valentis Director · filings 2004 to 2005

Date	Transaction	Shares	Held after	Source
Dec 2, 2005	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000	10,000 direct	Filing · EDGAR
Mar 8, 2005	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000	10,000 direct	Filing · EDGAR
Dec 3, 2004	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000	10,000 direct	Filing · EDGAR

All 225 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 2, 2026	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 31, 2026	Form 144	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 7, 2026	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jun 17, 2026	Form 4	Zenas BioPharma ZBIO	Filing · EDGAR
Jun 12, 2026	Form 4	BioAge Labs BIOA	Filing · EDGAR
May 26, 2026	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Feb 6, 2026	Form 4	Rapid Micro Biosystems RPID	Filing · EDGAR
Feb 5, 2026	Form 4	Veradermics MANE	Filing · EDGAR
Feb 3, 2026	Form 3	Veradermics MANE	Filing · EDGAR
Feb 3, 2026	Form 4	Rapid Micro Biosystems RPID	Filing · EDGAR
Jan 8, 2026	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Dec 15, 2025	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Oct 14, 2025	Form 4	Zenas BioPharma ZBIO	Filing · EDGAR
Aug 11, 2025	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 8, 2025	Form 144	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jun 25, 2025	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Jun 12, 2025	Form 4	Zenas BioPharma ZBIO	Filing · EDGAR
Jun 9, 2025	Form 4	BioAge Labs BIOA	Filing · EDGAR
May 16, 2025	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Sep 27, 2024	Form 4	BioAge Labs BIOA	Filing · EDGAR
Sep 25, 2024	Form 3	BioAge Labs BIOA	Filing · EDGAR
Sep 16, 2024	Form 4	Zenas BioPharma ZBIO	Filing · EDGAR
Sep 12, 2024	Form 3	Zenas BioPharma ZBIO	Filing · EDGAR
Aug 6, 2024	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
May 17, 2024	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Nov 9, 2023	Form 4	Lexeo Therapeutics	Filing · EDGAR
Nov 2, 2023	Form 3	Lexeo Therapeutics	Filing · EDGAR
Aug 15, 2023	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 14, 2023	Form 144	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
May 12, 2023	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Feb 8, 2023	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Nov 25, 2022	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 9, 2022	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
May 31, 2022	Form 4	Aptinyx	Filing · EDGAR
May 26, 2022	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Apr 29, 2022	Form 4	Sierra Oncology	Filing · EDGAR
Apr 21, 2022	Form 4	Inozyme Pharma	Filing · EDGAR
Apr 5, 2022	Form 4	Vera Therapeutics VERA	Filing · EDGAR
Feb 2, 2022	Form 4	Sierra Oncology	Filing · EDGAR
Jan 27, 2022	Form 4	Sierra Oncology	Filing · EDGAR
Aug 20, 2021	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 2, 2021	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 20, 2021	Form 4	Rapid Micro Biosystems RPID	Filing · EDGAR
Jul 14, 2021	Form 3	Rapid Micro Biosystems RPID	Filing · EDGAR
Jun 1, 2021	Form 4	Aptinyx	Filing · EDGAR
May 18, 2021	Form 4	Vera Therapeutics VERA	Filing · EDGAR
May 17, 2021	Form 4	Vera Therapeutics VERA	Filing · EDGAR
May 13, 2021	Form 3	Vera Therapeutics VERA	Filing · EDGAR
May 11, 2021	Form 4	Talaris Therapeutics	Filing · EDGAR
May 6, 2021	Form 3	Talaris Therapeutics	Filing · EDGAR
Apr 15, 2021	Form 4	Eargo	Filing · EDGAR
Jan 5, 2021	Form 4	Aptinyx	Filing · EDGAR
Nov 18, 2020	Form 4	89bio	Filing · EDGAR
Nov 13, 2020	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Nov 4, 2020	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Oct 22, 2020	Form 4	Eargo	Filing · EDGAR
Oct 15, 2020	Form 3	Eargo	Filing · EDGAR
Oct 14, 2020	Form 4	Aimmune Therapeutics	Filing · EDGAR
Oct 2, 2020	Form 4	Aptinyx	Filing · EDGAR
Sep 23, 2020	Form 4	Aimmune Therapeutics	Filing · EDGAR
Sep 1, 2020	Form 4	Molecular Templates	Filing · EDGAR
Aug 10, 2020	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 28, 2020	Form 4	Inozyme Pharma	Filing · EDGAR
Jul 23, 2020	Form 3	Inozyme Pharma	Filing · EDGAR
Jul 14, 2020	Form 4	89bio	Filing · EDGAR
Jul 2, 2020	Form 4	Aptinyx	Filing · EDGAR
Jun 11, 2020	Form 3	Vaxcyte	Filing · EDGAR
May 29, 2020	Form 4	Aimmune Therapeutics	Filing · EDGAR
May 28, 2020	Form 4	Molecular Templates	Filing · EDGAR
May 22, 2020	Form 4	Aptinyx	Filing · EDGAR
Apr 2, 2020	Form 4	Aptinyx	Filing · EDGAR
Mar 19, 2020	Form 4	Aimmune Therapeutics	Filing · EDGAR
Jan 31, 2020	Form 4	Sierra Oncology	Filing · EDGAR
Jan 14, 2020	Form 4	Aptinyx	Filing · EDGAR
Jan 3, 2020	Form 4	Aptinyx	Filing · EDGAR
Dec 5, 2019	Form 4/A	Molecular Templates	Filing · EDGAR
Nov 27, 2019	Form 4	Molecular Templates	Filing · EDGAR
Nov 26, 2019	Form 3	Sierra Oncology	Filing · EDGAR
Nov 13, 2019	Form 4	89bio	Filing · EDGAR
Nov 8, 2019	Form 3	89bio	Filing · EDGAR
Nov 7, 2019	Form 3	Venus Concept	Filing · EDGAR
Oct 2, 2019	Form 4	Aptinyx	Filing · EDGAR
Sep 19, 2019	Form 4	Aimmune Therapeutics	Filing · EDGAR
Aug 12, 2019	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 2, 2019	Form 4	Aptinyx	Filing · EDGAR
May 28, 2019	Form 4	Aimmune Therapeutics	Filing · EDGAR
May 17, 2019	Form 4	Aptinyx	Filing · EDGAR
Apr 2, 2019	Form 4	Aptinyx	Filing · EDGAR
Nov 2, 2018	Form 4	Axonics Modulation Technologies	Filing · EDGAR
Oct 30, 2018	Form 3	Axonics Modulation Technologies	Filing · EDGAR
Sep 25, 2018	Form 4	Molecular Templates	Filing · EDGAR
Sep 7, 2018	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 13, 2018	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 2, 2018	Form 4	Tricida	Filing · EDGAR
Jun 27, 2018	Form 3	Tricida	Filing · EDGAR
Jun 26, 2018	Form 4	Aptinyx	Filing · EDGAR
Jun 20, 2018	Form 3	Aptinyx	Filing · EDGAR
May 24, 2018	Form 4	Aimmune Therapeutics	Filing · EDGAR
Feb 26, 2018	Form 4	Aimmune Therapeutics	Filing · EDGAR
Dec 13, 2017	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Dec 12, 2017	Form 4	Collegium Pharmaceutical	Filing · EDGAR
Nov 21, 2017	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 28, 2017	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 14, 2017	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 7, 2017	Form 3	Molecular Templates	Filing · EDGAR
Jul 27, 2017	Form 4	Kala Pharmaceuticals	Filing · EDGAR
Jul 19, 2017	Form 3	Kala Pharmaceuticals	Filing · EDGAR
May 30, 2017	Form 4	Aimmune Therapeutics	Filing · EDGAR
Mar 20, 2017	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 15, 2017	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 10, 2017	Form 4	Corcept Therapeutics	Filing · EDGAR
Feb 27, 2017	Form 4	Corcept Therapeutics	Filing · EDGAR
Dec 14, 2016	Form 4	Corcept Therapeutics	Filing · EDGAR
Dec 6, 2016	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Dec 1, 2016	Form 4	Aimmune Therapeutics	Filing · EDGAR
Nov 30, 2016	Form 4	Corcept Therapeutics	Filing · EDGAR
Nov 25, 2016	Form 4	Corcept Therapeutics	Filing · EDGAR
Nov 21, 2016	Form 4	Corcept Therapeutics	Filing · EDGAR
Nov 17, 2016	Form 4	Corcept Therapeutics	Filing · EDGAR
Aug 17, 2016	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 15, 2016	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 25, 2016	Form 4	Corcept Therapeutics	Filing · EDGAR
May 27, 2016	Form 4	Aimmune Therapeutics	Filing · EDGAR
Mar 31, 2016	Form 4	Aimmune Therapeutics	Filing · EDGAR
Mar 31, 2016	Form 4	Aimmune Therapeutics	Filing · EDGAR
Feb 12, 2016	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 7, 2016	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Dec 3, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Nov 12, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Oct 7, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Sep 3, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 31, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 11, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 11, 2015	Form 4	Aimmune Therapeutics	Filing · EDGAR
Aug 11, 2015	Form 4	Aimmune Therapeutics	Filing · EDGAR
Aug 5, 2015	Form 3	Aimmune Therapeutics	Filing · EDGAR
Aug 5, 2015	Form 3	Aimmune Therapeutics	Filing · EDGAR
Jul 8, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jun 22, 2015	Form 4	Corcept Therapeutics	Filing · EDGAR
Jun 3, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
May 18, 2015	Form 4	Esperion Therapeutics	Filing · EDGAR
May 14, 2015	Form 4	Collegium Pharmaceutical	Filing · EDGAR
May 13, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
May 8, 2015	Form 3	Collegium Pharmaceutical	Filing · EDGAR
Apr 8, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Apr 1, 2015	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 24, 2015	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 23, 2015	Form 4	Esperion Therapeutics	Filing · EDGAR
Mar 4, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Feb 12, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 7, 2015	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Dec 16, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Dec 3, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Nov 19, 2014	Form 4	Esperion Therapeutics	Filing · EDGAR
Nov 12, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Oct 14, 2014	Form 4	Esperion Therapeutics	Filing · EDGAR
Oct 9, 2014	Form 4	Esperion Therapeutics	Filing · EDGAR
Oct 8, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Sep 4, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 14, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 11, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
May 16, 2014	Form 4	Esperion Therapeutics	Filing · EDGAR
May 12, 2014	Form 4	Corcept Therapeutics	Filing · EDGAR
May 5, 2014	Form 4	Corcept Therapeutics	Filing · EDGAR
Apr 3, 2014	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 7, 2014	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 4, 2014	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 14, 2013	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 12, 2013	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 1, 2013	Form 4	Esperion Therapeutics	Filing · EDGAR
Jun 25, 2013	Form 3	Esperion Therapeutics	Filing · EDGAR
May 21, 2013	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 7, 2013	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Feb 20, 2013	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 16, 2013	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 14, 2013	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 11, 2013	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Oct 4, 2012	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 13, 2012	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jun 15, 2012	Form 4	Corcept Therapeutics	Filing · EDGAR
Apr 2, 2012	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 9, 2012	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 18, 2012	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 18, 2012	Form 3	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 18, 2012	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 13, 2012	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Nov 8, 2011	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
May 23, 2011	Form 4	Corcept Therapeutics	Filing · EDGAR
Mar 14, 2011	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jan 25, 2011	Form 4	Corcept Therapeutics	Filing · EDGAR
Aug 27, 2010	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jun 24, 2010	Form 4	Corcept Therapeutics	Filing · EDGAR
May 13, 2010	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Apr 23, 2010	Form 4	Corcept Therapeutics	Filing · EDGAR
Oct 19, 2009	Form 4	Corcept Therapeutics	Filing · EDGAR
Sep 3, 2009	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Aug 19, 2009	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 9, 2009	Form 4	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jul 9, 2009	Form 3	Jazz Pharmaceuticals JAZZ	Filing · EDGAR
Jun 15, 2009	Form 4	Corcept Therapeutics	Filing · EDGAR
Feb 10, 2009	Form 4	Corcept Therapeutics	Filing · EDGAR
Nov 13, 2008	Form 4	Corcept Therapeutics	Filing · EDGAR
Jun 24, 2008	Form 4	Corcept Therapeutics	Filing · EDGAR
Apr 4, 2008	Form 3	Corcept Therapeutics	Filing · EDGAR
Jun 26, 2007	Form 4	Sequenom	Filing · EDGAR
Mar 2, 2007	Form 4	Molecular Templates	Filing · EDGAR
Dec 11, 2006	Form 4	Sequenom	Filing · EDGAR
Dec 11, 2006	Form 4	Sequenom	Filing · EDGAR
Oct 3, 2006	Form 4/A	Molecular Templates	Filing · EDGAR
Sep 29, 2006	Form 4	Molecular Templates	Filing · EDGAR
Sep 27, 2006	Form 4	Molecular Templates	Filing · EDGAR
Sep 7, 2006	Form 4	Molecular Templates	Filing · EDGAR
Jun 8, 2006	Form 4	Sequenom	Filing · EDGAR
Jun 8, 2006	Form 3	Sequenom	Filing · EDGAR
Apr 24, 2006	Form 4	Molecular Templates	Filing · EDGAR
Apr 24, 2006	Form 4	Molecular Templates	Filing · EDGAR
Mar 7, 2006	Form 4	Molecular Templates	Filing · EDGAR
Mar 7, 2006	Form 4	Molecular Templates	Filing · EDGAR
Dec 5, 2005	Form 4	Valentis	Filing · EDGAR
Nov 1, 2005	Form 4	Molecular Templates	Filing · EDGAR
May 23, 2005	Form 4	Molecular Templates	Filing · EDGAR
Mar 9, 2005	Form 4	Valentis	Filing · EDGAR
Feb 9, 2005	Form 4	Molecular Templates	Filing · EDGAR
Feb 3, 2005	Form 3	Molecular Templates	Filing · EDGAR
Dec 6, 2004	Form 4	Valentis	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 1:00 AM ET. The filing on SEC.gov is the record.